SE358641

1,227,042. 5 - Methyl - 3 - (2,6 - dichlorophenyl) - 4 - isoxazotyl - penicillin, magnesium salt. TAKEDA YAKUHIN KOGYO K.K. 18 Feb., 1969 [19 Feb., 1968; 7 Feb., 1969], No. 8630/69. Heading C2A. Novel magnesium salts of 5-methyl-3-(2,6- dichlorophenyl) - 4 - isoxazolyl - penicillin are prepared by c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: AOKI K,JA, FUJISAWA H,JA, SUGIMOTO K,JA, MATSUZAWA T,JA, KITAMORI N,JA, MIMA H,JA, KAWAJIRI S,JA
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator AOKI K,JA
FUJISAWA H,JA
SUGIMOTO K,JA
MATSUZAWA T,JA
KITAMORI N,JA
MIMA H,JA
KAWAJIRI S,JA
description 1,227,042. 5 - Methyl - 3 - (2,6 - dichlorophenyl) - 4 - isoxazotyl - penicillin, magnesium salt. TAKEDA YAKUHIN KOGYO K.K. 18 Feb., 1969 [19 Feb., 1968; 7 Feb., 1969], No. 8630/69. Heading C2A. Novel magnesium salts of 5-methyl-3-(2,6- dichlorophenyl) - 4 - isoxazolyl - penicillin are prepared by contacting a solution of 5-methyl- 3 - (2,6 - dichlorophenyl) - 4 - isoxazolylpenicillin or its salt of a metal exchangeable with magnesium with a solution of a magnesium ion donor such as the magnesium salts of organic or inorganic acids. The product may have a particle size of 1-2 microns. Pharmaceutical compositions comprise the novel magnesium salt and a carrier or adjuvant. An injectable composition comprises the magnesium salt, water, a magnesium cation donor, buffer agent, an isotonic agent and a suspending agent. Other conventional additives may also be present.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SE358641B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SE358641B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SE358641B3</originalsourceid><addsrcrecordid>eNrjZOAIdjU2tTAzMeRhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfEw5U7GBBUAAGEDGaI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SE358641</title><source>esp@cenet</source><creator>AOKI K,JA ; FUJISAWA H,JA ; SUGIMOTO K,JA ; MATSUZAWA T,JA ; KITAMORI N,JA ; MIMA H,JA ; KAWAJIRI S,JA</creator><creatorcontrib>AOKI K,JA ; FUJISAWA H,JA ; SUGIMOTO K,JA ; MATSUZAWA T,JA ; KITAMORI N,JA ; MIMA H,JA ; KAWAJIRI S,JA</creatorcontrib><description>1,227,042. 5 - Methyl - 3 - (2,6 - dichlorophenyl) - 4 - isoxazotyl - penicillin, magnesium salt. TAKEDA YAKUHIN KOGYO K.K. 18 Feb., 1969 [19 Feb., 1968; 7 Feb., 1969], No. 8630/69. Heading C2A. Novel magnesium salts of 5-methyl-3-(2,6- dichlorophenyl) - 4 - isoxazolyl - penicillin are prepared by contacting a solution of 5-methyl- 3 - (2,6 - dichlorophenyl) - 4 - isoxazolylpenicillin or its salt of a metal exchangeable with magnesium with a solution of a magnesium ion donor such as the magnesium salts of organic or inorganic acids. The product may have a particle size of 1-2 microns. Pharmaceutical compositions comprise the novel magnesium salt and a carrier or adjuvant. An injectable composition comprises the magnesium salt, water, a magnesium cation donor, buffer agent, an isotonic agent and a suspending agent. Other conventional additives may also be present.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>1973</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19730806&amp;DB=EPODOC&amp;CC=SE&amp;NR=358641B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19730806&amp;DB=EPODOC&amp;CC=SE&amp;NR=358641B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>AOKI K,JA</creatorcontrib><creatorcontrib>FUJISAWA H,JA</creatorcontrib><creatorcontrib>SUGIMOTO K,JA</creatorcontrib><creatorcontrib>MATSUZAWA T,JA</creatorcontrib><creatorcontrib>KITAMORI N,JA</creatorcontrib><creatorcontrib>MIMA H,JA</creatorcontrib><creatorcontrib>KAWAJIRI S,JA</creatorcontrib><title>SE358641</title><description>1,227,042. 5 - Methyl - 3 - (2,6 - dichlorophenyl) - 4 - isoxazotyl - penicillin, magnesium salt. TAKEDA YAKUHIN KOGYO K.K. 18 Feb., 1969 [19 Feb., 1968; 7 Feb., 1969], No. 8630/69. Heading C2A. Novel magnesium salts of 5-methyl-3-(2,6- dichlorophenyl) - 4 - isoxazolyl - penicillin are prepared by contacting a solution of 5-methyl- 3 - (2,6 - dichlorophenyl) - 4 - isoxazolylpenicillin or its salt of a metal exchangeable with magnesium with a solution of a magnesium ion donor such as the magnesium salts of organic or inorganic acids. The product may have a particle size of 1-2 microns. Pharmaceutical compositions comprise the novel magnesium salt and a carrier or adjuvant. An injectable composition comprises the magnesium salt, water, a magnesium cation donor, buffer agent, an isotonic agent and a suspending agent. Other conventional additives may also be present.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1973</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZOAIdjU2tTAzMeRhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfEw5U7GBBUAAGEDGaI</recordid><startdate>19730806</startdate><enddate>19730806</enddate><creator>AOKI K,JA</creator><creator>FUJISAWA H,JA</creator><creator>SUGIMOTO K,JA</creator><creator>MATSUZAWA T,JA</creator><creator>KITAMORI N,JA</creator><creator>MIMA H,JA</creator><creator>KAWAJIRI S,JA</creator><scope>EVB</scope></search><sort><creationdate>19730806</creationdate><title>SE358641</title><author>AOKI K,JA ; FUJISAWA H,JA ; SUGIMOTO K,JA ; MATSUZAWA T,JA ; KITAMORI N,JA ; MIMA H,JA ; KAWAJIRI S,JA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SE358641B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1973</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>AOKI K,JA</creatorcontrib><creatorcontrib>FUJISAWA H,JA</creatorcontrib><creatorcontrib>SUGIMOTO K,JA</creatorcontrib><creatorcontrib>MATSUZAWA T,JA</creatorcontrib><creatorcontrib>KITAMORI N,JA</creatorcontrib><creatorcontrib>MIMA H,JA</creatorcontrib><creatorcontrib>KAWAJIRI S,JA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>AOKI K,JA</au><au>FUJISAWA H,JA</au><au>SUGIMOTO K,JA</au><au>MATSUZAWA T,JA</au><au>KITAMORI N,JA</au><au>MIMA H,JA</au><au>KAWAJIRI S,JA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SE358641</title><date>1973-08-06</date><risdate>1973</risdate><abstract>1,227,042. 5 - Methyl - 3 - (2,6 - dichlorophenyl) - 4 - isoxazotyl - penicillin, magnesium salt. TAKEDA YAKUHIN KOGYO K.K. 18 Feb., 1969 [19 Feb., 1968; 7 Feb., 1969], No. 8630/69. Heading C2A. Novel magnesium salts of 5-methyl-3-(2,6- dichlorophenyl) - 4 - isoxazolyl - penicillin are prepared by contacting a solution of 5-methyl- 3 - (2,6 - dichlorophenyl) - 4 - isoxazolylpenicillin or its salt of a metal exchangeable with magnesium with a solution of a magnesium ion donor such as the magnesium salts of organic or inorganic acids. The product may have a particle size of 1-2 microns. Pharmaceutical compositions comprise the novel magnesium salt and a carrier or adjuvant. An injectable composition comprises the magnesium salt, water, a magnesium cation donor, buffer agent, an isotonic agent and a suspending agent. Other conventional additives may also be present.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_SE358641B
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title SE358641
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T17%3A05%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=AOKI%20K,JA&rft.date=1973-08-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESE358641B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true